[Hemoglobin H disease. Presentation of a case]. 1986

P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi

Haemoglobin H (Hb H) disease, the most important clinical form of alpha-thalassaemia, shows remarkable clinical variability. Hb H si an unstable tetramer of beta-globin chains which accumulates because of the lack of adequate numbers of alpha-globin chains and precipitates in the red cells, causing their premature destruction. A case of Hb H disease in a 9-yr-old child, admitted into hospital for acute haemolysis after use of pyrazolone derived, is presented. Haematologic data with synthesis in vitro of globin chains were obtained from the parents and sister. The clinical and haematologic features of this form of haemoglobinopathy are briefly discussed in the light of recent knowledges of his genetic mechanism of transmission.

UI MeSH Term Description Entries
D008297 Male Males
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D047069 Pyrazolones Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production. Pyrazolin-5-Ones,Pyrazolin 5 Ones

Related Publications

P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
January 1970, La Pediatria,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
January 1970, The Turkish journal of pediatrics,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
November 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
August 1971, Minerva pediatrica,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
September 1958, A.M.A. archives of internal medicine,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
October 1966, Blood,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
May 1958, Blood,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
November 1971, The New England journal of medicine,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
November 2009, Annals of hematology,
P Morelli, and A Silva, and F Valli, and A Massa, and N M Sposi
January 1998, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!